BACKGROUND: Drug-eluting stenting reduces restenosis post-percutaneous coronary intervention (PCI), but subgroups of patients may not benefit optimally from this procedure. We examined the impact of Type D personality on health status over time and the clinical relevance of Type D as a predictor of impaired health status at 12 months in unselected post-PCI patients. METHODS: Consecutive patients (n=692) participating in the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry completed the Type D Scale at 6 months and the Short Form Health Survey 36 (SF-36) at 6 and 12 months post-PCI. RESULTS: Although there was a significant improvement in health status over time (p<0.001), Type D patients reported a substantially lower score on all health status domains of the SF-36 compared with non-Type D patients (p<0.001). Type D personality was an independent predictor of impaired health status on all SF-36 sub domains at 12 months except for physical functioning, adjusting for baseline demographic and clinical variables and health status at 6 months. In these adjusted analyses, Type D personality increased the likelihood of impaired health status at 12 months post-PCI from 60% (OR: 1.60; 95% CI: 1.04-2.46) to almost 300% (OR: 3.99; 95% CI: 2.52-6.32), varying among the parameters analyzed. CONCLUSIONS: Type D personality was associated with impaired health status in post-PCI patients treated in the drug-eluting stent era. The role of personality factors as determinants of clinical outcome and health status should not be overlooked as these factors may have much explanatory power.
BACKGROUND: Drug-eluting stenting reduces restenosis post-percutaneous coronary intervention (PCI), but subgroups of patients may not benefit optimally from this procedure. We examined the impact of Type D personality on health status over time and the clinical relevance of Type D as a predictor of impaired health status at 12 months in unselected post-PCI patients. METHODS: Consecutive patients (n=692) participating in the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry completed the Type D Scale at 6 months and the Short Form Health Survey 36 (SF-36) at 6 and 12 months post-PCI. RESULTS: Although there was a significant improvement in health status over time (p<0.001), Type D patients reported a substantially lower score on all health status domains of the SF-36 compared with non-Type D patients (p<0.001). Type D personality was an independent predictor of impaired health status on all SF-36 sub domains at 12 months except for physical functioning, adjusting for baseline demographic and clinical variables and health status at 6 months. In these adjusted analyses, Type D personality increased the likelihood of impaired health status at 12 months post-PCI from 60% (OR: 1.60; 95% CI: 1.04-2.46) to almost 300% (OR: 3.99; 95% CI: 2.52-6.32), varying among the parameters analyzed. CONCLUSIONS: Type D personality was associated with impaired health status in post-PCI patients treated in the drug-eluting stent era. The role of personality factors as determinants of clinical outcome and health status should not be overlooked as these factors may have much explanatory power.
Authors: Erla Svansdottir; Hrobjartur D Karlsson; Thorarinn Gudnason; Daniel T Olason; Hordur Thorgilsson; Unnur Sigtryggsdottir; Eric J Sijbrands; Susanne S Pedersen; Johan Denollet Journal: J Behav Med Date: 2011-04-28
Authors: Erla Svansdottir; Krista C van den Broek; Hrobjartur D Karlsson; Thorarinn Gudnason; Johan Denollet Journal: BMC Public Health Date: 2012-01-18 Impact factor: 3.295
Authors: Patrizia Steca; Marco D'Addario; Maria Elena Magrin; Massimo Miglioretti; Dario Monzani; Luca Pancani; Marcello Sarini; Marta Scrignaro; Luca Vecchio; Francesco Fattirolli; Cristina Giannattasio; Francesca Cesana; Salvatore Pio Riccobono; Andrea Greco Journal: PLoS One Date: 2016-09-02 Impact factor: 3.240
Authors: Milos Slepecky; Antonia Kotianova; Jan Prasko; Ivan Majercak; Michal Kotian; Erika Gyorgyova; Marta Zatkova; Michaela Chupacova; Marie Ociskova; Tomas Sollar Journal: Psychol Res Behav Manag Date: 2019-07-04
Authors: Susanne S Pedersen; Andriy Yagensky; Otto R F Smith; Oksana Yagenska; Volodymyr Shpak; Johan Denollet Journal: Int J Behav Med Date: 2009-02-20